Presentation is loading. Please wait.

Presentation is loading. Please wait.

Efficacy of Reduced-Intensity Allogeneic Stem Cell Transplantation in Chemotherapy- Refractory Non-Hodgkin Lymphoma  Robert M. Dean, Daniel H. Fowler,

Similar presentations


Presentation on theme: "Efficacy of Reduced-Intensity Allogeneic Stem Cell Transplantation in Chemotherapy- Refractory Non-Hodgkin Lymphoma  Robert M. Dean, Daniel H. Fowler,"— Presentation transcript:

1 Efficacy of Reduced-Intensity Allogeneic Stem Cell Transplantation in Chemotherapy- Refractory Non-Hodgkin Lymphoma  Robert M. Dean, Daniel H. Fowler, Wyndham H. Wilson, Jeanne Odom, Seth M. Steinberg, Catherine Chow, Claude Kasten-Sportes, Ronald E. Gress, Michael R. Bishop  Biology of Blood and Marrow Transplantation  Volume 11, Issue 8, Pages (August 2005) DOI: /j.bbmt Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions

2 Figure 1 Overall survival after RIST according to response to EPOCH-F. Responses to EPOCH-F were categorized as complete or partial response (CR/PR), stable disease (SD), or progressive disease (PD). Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions

3 Figure 2 Event-free survival after RIST. SD indicates stable disease.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions


Download ppt "Efficacy of Reduced-Intensity Allogeneic Stem Cell Transplantation in Chemotherapy- Refractory Non-Hodgkin Lymphoma  Robert M. Dean, Daniel H. Fowler,"

Similar presentations


Ads by Google